5Suppliers
3Customers
3Debt Items
6Related Chains

Lifeward Ltd. Suppliers

TickerNameConfidenceEvidence
ORMP Oramed Pharmaceuticals Inc. 92% Proposal No. 1: To approve the Company's issuance of Ordinary Shares, as described in the Proxy Statement, (a) to Oramed, as consideration for the acquisition of 100% of the outstanding shares of Ora…
ORMP Oramed Pharmaceuticals Inc. 92% Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Proposal No. 1: To approve the Company's issuance of Ordinary Shares, as described in the Proxy Statement, (a) to Ora…
ORATECH-LTD ORATECH-LTD 90% the rights and obligations of Oratech Pharma under the Share Purchase Agreement were assigned to Oratech Ltd.
ORATECH-PHARMA ORATECH-PHARMA 90% Oratech Pharma transferred and assigned all of its rights, title and interest under the Share Purchase Agreement to Oratech
ORAMED ORAMED 80% The Subsequent Secured Promissory Note contains customary representations, warranties and covenants limiting additional indebtedness, liens, guaranties, mergers and consolidations, substantial asset …

Lifeward Ltd. Customers

TickerNameConfidenceEvidence
ORMP Oramed Pharmaceuticals Inc. 92% Reciprocal relationship from ORMP graph: At the Notes Closing, Lifeward issued to the Company (i) $9,000,000.00 aggregate principal amount of the Notes with an initial conversion price equal to $5.40…
ORAMED ORAMED 85% the Company entered into a securities purchase agreement with Oramed, certain investors and Oramed, as collateral agent
LFWD Lifeward Ltd. 70% the Company issued $10,000,000.00 aggregate principal amount senior secured convertible notes

Lifeward Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
LFWD-DEBT-10677 Xbrl Convertible 90% xbrl convertible detail from xbrl 2015-12-31.
LFWD-DEBT-10676 Warrants outstanding: 513930 90% xbrl warrant detail from xbrl 2025-12-31.
LFWD-DEBT Debt stack $8.8M 90% Market cache reports total debt of $8.8M.

Lifeward Ltd. Acquisitions

Acquired EntityNameConfidenceEvidence
LFWD-ACQ-0001178913-26-000244 The Company intends to issue ordinary shares to Oramed as consideration for the acquisition of 1... 85% The Company intends to issue ordinary shares to Oramed as consideration for the acquisition of 100% of the outstanding shares of Oratech.
LFWD-ACQ-0001178913-26-000642 Lifeward Ltd. will issue ordinary shares as part of the consideration for acquiring assets from ... 85% Lifeward Ltd. will issue ordinary shares as part of the consideration for acquiring assets from Skelable Ltd.
LFWD-ACQ-0001178913-26-001724 The Company issued 1,296,296 warrants to purchase Ordinary Shares as part of the acquisition of ... 85% The Company issued 1,296,296 warrants to purchase Ordinary Shares as part of the acquisition of Oratech Pharma.
LFWD-ACQ-0001178913-26-000875 Approval for the issuance of Ordinary Shares to Oramed Pharmaceuticals Inc. as consideration for... 85% Approval for the issuance of Ordinary Shares to Oramed Pharmaceuticals Inc. as consideration for the acquisition of 100% of the outstanding shares of Oratech Pharma, Inc.

Lifeward Ltd. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Lifeward Ltd..

Lifeward Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SCLX Scilex Holding Company 100.00 2
ORMP Oramed Pharmaceuticals Inc. 59.25 1 ['customer', 'supplier']
ORAMED ORAMED 54.19 1 ['receiving']
SMNR Semnur Pharmaceuticals, Inc. 50.00 2
NNDM Nano Dimension Ltd. 24.13 2
PTHS Pelthos Therapeutics Inc. 24.13 2